УСЛОВИЯ КУЛЬТИВИРОВАНИЯ И ВЫДЕЛЕНИЯ ПРИРОДНОГО АНТИБИОТИКА № 360, АКТИВНОГО ПРОТИВ МЕТИЦИЛЛИНРЕЗИСТЕНТНЫХ СТАФИЛОКОККОВ С МНОЖЕСТВЕННОЙ ЛЕКАРСТВЕННОЙ УСТОЙЧИВОСТЬЮ
Ключевые слова:
стафилококктар, антибиотикті өсіру,Аннотация
360 антибиотикті өсірудің жəне бөлудің ұтымды жағдайы іріктеп алынған. Антибиотик метициллинрезистенттік көптік дəрілік тұрақтылықты стафилококктарға қарсы жоғары белсенділігі бар.Библиографические ссылки
1. Singer R.S., Finch R., Wegener H.C., Bywater R., Walters J., Lipsitch M. Antibiotic resistance – the interplay between antibiotic use in animals and human beings//The Lancet Infect. Dis. - 2003. - №3. - P.47-51.
2. Talbot, G.H., Bradley J., Edwards. J.E., Gilbert D., Scheld M., J.G. Bartlett J.G. Bad bags Need Drugs: An update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America//Clin. Infect. Dis.- 2006. - №42. - P. 657-668.
3. Marchese A.S., Schito C., Debbia E.A. Evolution of antibiotic resistance in grampositive pathogenes //J. of Сhemother. - 2000.- V. 12, - № 6. - Р. 259-462.
4. Embil J., Almunnef М., Nicole D., Makki S., Cunningham G., Wylie J., Nicole L., Memish Z. Methicillinresistant Staphylococcus aureus: Profiles oceans apart Canadian and Saudi Arabian experiences // J. Chemother. -
2001. - V. 13. - № 1. - Р. 28-33.
5. Афанасьева Т.И. Метициллинорезистентные стафилококки // Антибиотики и химиотерапия. - 1998. -Т. 43. - № 6. - С. 29-31.
6. Zhang, A., Demain A.L. Natural Products. Drug Discovery and Therapeutical Medicine. - 2005. – 382 p.
7. Newman, D.J., Cragg M.G. Natural products as sources of new drugs over the last 25 years//J. Nat. Prod. - 2007. - V.70. - P. 461-477.
8. Demain A.L. Pharmaceutically active secondary metabolites of microorganisms//Appl. Microbiol. Biotechnol. - 1999. - V. 52. - P. 455–63.
2. Talbot, G.H., Bradley J., Edwards. J.E., Gilbert D., Scheld M., J.G. Bartlett J.G. Bad bags Need Drugs: An update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America//Clin. Infect. Dis.- 2006. - №42. - P. 657-668.
3. Marchese A.S., Schito C., Debbia E.A. Evolution of antibiotic resistance in grampositive pathogenes //J. of Сhemother. - 2000.- V. 12, - № 6. - Р. 259-462.
4. Embil J., Almunnef М., Nicole D., Makki S., Cunningham G., Wylie J., Nicole L., Memish Z. Methicillinresistant Staphylococcus aureus: Profiles oceans apart Canadian and Saudi Arabian experiences // J. Chemother. -
2001. - V. 13. - № 1. - Р. 28-33.
5. Афанасьева Т.И. Метициллинорезистентные стафилококки // Антибиотики и химиотерапия. - 1998. -Т. 43. - № 6. - С. 29-31.
6. Zhang, A., Demain A.L. Natural Products. Drug Discovery and Therapeutical Medicine. - 2005. – 382 p.
7. Newman, D.J., Cragg M.G. Natural products as sources of new drugs over the last 25 years//J. Nat. Prod. - 2007. - V.70. - P. 461-477.
8. Demain A.L. Pharmaceutically active secondary metabolites of microorganisms//Appl. Microbiol. Biotechnol. - 1999. - V. 52. - P. 455–63.
Загрузки
Выпуск
Раздел
БИОТЕХНОЛОГИЯ
